INS and cardiovascular disorder: Adjusting for demographics, cardiovascular disease, and eGFR (Model 2) each doubling of CPM was associated with a 0.9 (mg/min)/(μU/mL) higher insulin sensitivity (95% CI 0.2,1.5 (mg/min)/(μU/mL), p = 0.006), an 8 kg lower fat mass (95% CI −12.9, −3.1 kg, p = 0.001), and a 37.9 mg/dL lower triglyceride concentration (95% CI −71.9, −3.9 mg/dL, p = 0.03) (Table 3).